股本结构
单位：万股
| 公告日期 | 2026-10-09 | 2026-08-13 | 2026-08-13 | 2026-05-13 | 2026-03-31 | 2026-03-31 |
|---|---|---|---|---|---|---|
| 证券总股本 | 797.99 | 748.32 | 747.31 | 747.19 | 747.19 | 744.83 |
| 普通股本 | 797.99 | 748.32 | 747.31 | 747.19 | 747.19 | 744.83 |
| 优先股 | 未披露 | 未披露 | 1.17 | 1.17 | 未披露 | 1.17 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-10-01 | 2026-08-13 | 2026-06-30 | 2026-03-31 | 2026-03-30 | 2025-12-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-10-09 | 797.99 | 未披露 | 定期报告 | 2026-10-01 |
| 2026-08-13 | 748.32 | 未披露 | 定期报告 | 2026-08-13 |
| 2026-08-13 | 747.31 | 1.17 |
更多>>
From April 1,2026 to June 30,2026
Issuance of common stock for consulting fees
|
2026-06-30 |
| 2026-05-13 | 747.19 | 1.17 |
更多>>
From January 1,2026 to March 31,2026
Issuance of common stock for consulting fees
|
2026-03-31 |
| 2026-03-31 | 747.19 | 未披露 | 定期报告 | 2026-03-30 |
| 2026-03-31 | 744.83 | 1.17 |
更多>>
From January 1, 2025 to December 31, 2025
Stock based compensation
Exercise of investor warrants
Issuance of common stock for consulting fees
Preferred stock redemptions and conversions
|
2025-12-31 |
| 2026-01-02 | 744.83 | 未披露 | 定期报告 | 2025-12-29 |
| 2025-11-14 | 712.89 | 未披露 | 定期报告 | 2025-11-11 |
| 2025-11-12 | 671.89 | 未披露 | 定期报告 | 2025-10-31 |
| 2025-11-14 | 452.74 | 0.12 |
更多>>
From July 1, 2025 to September 30, 2025
Preferred stock redemptions and conversions
Exercise of investor warrants
Issuance of common stock for consulting fees
|
2025-09-30 |
| 2025-08-14 | 348.71 | 未披露 | 定期报告 | 2025-08-12 |
| 2025-08-14 | 250.49 | 0.57 |
更多>>
From April 1, 2025 to June 30, 2025
Issuance of Series D preferred stock and warrants
Preferred stock redemptions and conversions
Stock based compensation
Exercise of investor warrants
Issuance of common stock for consulting fees
Preferred stock redemptions and conversions
|
2025-06-30 |
| 2025-07-07 | 216.37 | 未披露 | 定期报告 | 2025-06-20 |
| 2025-07-07 | 139.17 | 未披露 | 定期报告 | 2025-06-09 |
| 2025-03-27 | 138.98 | 未披露 | 定期报告 | 2025-03-25 |
| 2025-03-27 | 135.72 | 0.43 |
更多>>
From January 1, 2024 to December 31, 2024
Preferred stock redemptions and conversions
Issuance of common stock for consulting fees
|
2024-12-31 |
| 2024-11-12 | 135.56 | 0.50 |
更多>>
From July 1, 2024 to September 30, 2024
Issuance of common stock for consulting fees
Preferred stock redemptions and conversions
Issuance of Preferred Stock
|
2024-09-30 |
| 2024-09-12 | 176.26 | 未披露 |
更多>>
Registered Series C Shares offered 448,250 shares by the company
|
2024-09-12 |
| 2024-08-14 | 131.43 | 未披露 | 定期报告 | 2024-08-13 |
| 2024-08-14 | 125.43 | 未披露 |
更多>>
From January 1, 2024 to June 30, 2024
Accrual of preferred stock and dividend redemption
Preferred stock redemptions and conversions
Issuance of common stock for consulting fees
|
2024-06-30 |
| 2024-05-15 | 123.32 | 未披露 | 定期报告 | 2024-05-13 |
| 2024-04-04 | 108.53 | 未披露 |
更多>>
Synaptogenix, Inc. effect a one-time reverse stock split of the Company’s common stock, at a ratio of 1-for-25,The Reverse Stock Split was effective at 5:00 p.m. Eastern Time, after the close of trading on The Nasdaq Capital Market, on April 4, 2024.
|
2024-04-05 |
| 2024-04-01 | 2713.33 | 未披露 | 定期报告 | 2024-03-25 |
| 2024-04-01 | 2408.96 | 0.60 |
更多>>
From January 1, 2023 to December 31, 2023
Preferred stock redemptions and conversions
Accrual of preferred stock and dividend redemption
Issuance of common stock for consulting fees
Deemed dividends on preferred stock
|
2023-12-31 |
| 2023-11-13 | 2039.08 | 未披露 | 定期报告 | 2023-11-09 |
| 2023-11-13 | 1934.08 | 未披露 | 定期报告 | 2023-10-27 |
| 2023-11-14 | 1751.07 | 0.90 |
更多>>
From July 1, 2023 to September 30, 2023
Preferred stock redemptions and conversions
Accrual of preferred stock and dividend redemption
Deemed dividends on preferred stock
|
2023-09-30 |
| 2023-08-14 | 1016.45 | 未披露 | 定期报告 | 2023-08-10 |
| 2023-08-14 | 736.53 | 1.40 |
更多>>
From April 1, 2023 to June 30, 2023
Issuance of common stock for consulting fees
Preferred stock redemptions
|
2023-06-30 |
| 2023-05-15 | 735.99 | 1.50 |
更多>>
From January 1, 2023 to March 31, 2023
Issuance of common stock for consulting fees
|
2023-03-31 |
| 2023-03-21 | 735.54 | 未披露 | 定期报告 | 2023-03-15 |
| 2023-03-21 | 726.70 | 1.50 |
更多>>
From January 1, 2022 to December 31, 2022
Exercise of common stock warrants
Issuance of common stock for consulting fees
Issuance of Series B Preferred Stock, net of discount and issuance costs of $12,278,277
Exercise of restricted stock units
|
2022-12-31 |
| 2023-01-09 | 726.70 | 未披露 | 定期报告 | 2022-12-20 |
| 2022-12-16 | 685.51 | 未披露 | 定期报告 | 2022-11-30 |
| 2022-11-10 | 684.80 | 未披露 | 定期报告 | 2022-11-05 |
| 2022-11-10 | 684.12 | 未披露 |
更多>>
From July 1, 2022 to September 30, 2022
Issuance of common stock for consulting fees
|
2022-09-30 |
| 2022-08-05 | 684.06 | 未披露 | 定期报告 | 2022-08-05 |
| 2022-08-05 | 681.03 | 未披露 |
更多>>
From April 1, 2022 to June 30, 2022
Issuance of common stock for consulting fees
|
2022-06-30 |
| 2022-05-13 | 680.96 | 未披露 |
更多>>
From January 1, 2022 to March 31, 2022
Issuance of common stock for consulting fees
Exercise of common stock warrants
|
2022-03-31 |
| 2022-03-29 | 680.96 | 未披露 | 定期报告 | 2022-03-20 |
| 2022-03-29 | 673.02 | 未披露 |
更多>>
From January 1, 2021 to December 31, 2021
Reverse stock split redemptions
Issuance of common stock for consulting fees
Private placements of common stock and warrants
Exercise of common stock warrants
|
2021-12-31 |
| 2021-11-12 | 667.45 | 未披露 | 定期报告 | 2021-11-10 |
| 2021-11-12 | 613.70 | 未披露 |
更多>>
From July 1, 2021 to September 30, 2021
Issuance of common stock for consulting fees
Exercise of common stock warrants
|
2021-09-30 |
| 2021-08-13 | 613.63 | 未披露 | 定期报告 | 2021-08-10 |
| 2021-08-13 | 603.88 | 未披露 |
更多>>
From April 1, 2021 to June 30, 2021
Reverse stock split rounding
Issuance of common stock for consulting fees
Private placement of common stock and warrants
Exercise of common stock warrants
|
2021-06-30 |
| 2021-06-24 | 558.07 | 未披露 | 定期报告 | 2021-06-21 |
| 2021-06-07 | 350.81 | 未披露 | 定期报告 | 2021-06-07 |
From April 1,2026 to June 30,2026
Issuance of common stock for consulting fees
From January 1,2026 to March 31,2026
Issuance of common stock for consulting fees
From January 1, 2025 to December 31, 2025
Stock based compensation
Exercise of investor warrants
Issuance of common stock for consulting fees
Preferred stock redemptions and conversions
From July 1, 2025 to September 30, 2025
Preferred stock redemptions and conversions
Exercise of investor warrants
Issuance of common stock for consulting fees
From April 1, 2025 to June 30, 2025
Issuance of Series D preferred stock and warrants
Preferred stock redemptions and conversions
Stock based compensation
Exercise of investor warrants
Issuance of common stock for consulting fees
Preferred stock redemptions and conversions
From January 1, 2024 to December 31, 2024
Preferred stock redemptions and conversions
Issuance of common stock for consulting fees
From July 1, 2024 to September 30, 2024
Issuance of common stock for consulting fees
Preferred stock redemptions and conversions
Issuance of Preferred Stock
Registered Series C Shares offered 448,250 shares by the company
From January 1, 2024 to June 30, 2024
Accrual of preferred stock and dividend redemption
Preferred stock redemptions and conversions
Issuance of common stock for consulting fees
Synaptogenix, Inc. effect a one-time reverse stock split of the Company’s common stock, at a ratio of 1-for-25,The Reverse Stock Split was effective at 5:00 p.m. Eastern Time, after the close of trading on The Nasdaq Capital Market, on April 4, 2024.
From January 1, 2023 to December 31, 2023
Preferred stock redemptions and conversions
Accrual of preferred stock and dividend redemption
Issuance of common stock for consulting fees
Deemed dividends on preferred stock
From July 1, 2023 to September 30, 2023
Preferred stock redemptions and conversions
Accrual of preferred stock and dividend redemption
Deemed dividends on preferred stock
From April 1, 2023 to June 30, 2023
Issuance of common stock for consulting fees
Preferred stock redemptions
From January 1, 2023 to March 31, 2023
Issuance of common stock for consulting fees
From January 1, 2022 to December 31, 2022
Exercise of common stock warrants
Issuance of common stock for consulting fees
Issuance of Series B Preferred Stock, net of discount and issuance costs of $12,278,277
Exercise of restricted stock units
From July 1, 2022 to September 30, 2022
Issuance of common stock for consulting fees
From April 1, 2022 to June 30, 2022
Issuance of common stock for consulting fees
From January 1, 2022 to March 31, 2022
Issuance of common stock for consulting fees
Exercise of common stock warrants
From January 1, 2021 to December 31, 2021
Reverse stock split redemptions
Issuance of common stock for consulting fees
Private placements of common stock and warrants
Exercise of common stock warrants
From July 1, 2021 to September 30, 2021
Issuance of common stock for consulting fees
Exercise of common stock warrants
From April 1, 2021 to June 30, 2021
Reverse stock split rounding
Issuance of common stock for consulting fees
Private placement of common stock and warrants
Exercise of common stock warrants